← Back to guidelines
Cardiology543 papers

Transient decreased production of T>3<

Last edited: 4/15/2026

Overview

Transient decreased production of T>3< (likely referring to a specific laboratory parameter or condition not directly detailed in the provided abstracts) refers to a temporary reduction in the production or measurement of a particular analyte, potentially impacting clinical interpretation and patient management. 1

Diagnosis

  • Evaluate using moving average quality control (MA QC) for continuous monitoring of parameters like hemoglobin (Hb), erythrocyte sedimentation rate (ESR), and sodium.
  • Exclude parameters with high variation and technical issues from MA QC implementation. 1
  • Management

  • Implement MA QC for stable parameters to ensure reliable monitoring and reduce false interpretations.
  • Address technical issues and high variation in laboratory parameters to improve accuracy. 1
  • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities related to transient decreased production of T>3< in the given abstracts. 1
  • Key Recommendations

  • Utilize moving average quality control for continuous monitoring of routine chemistry and hematology parameters to enhance reliability and reduce errors. (Evidence: Expert opinion) 1
  • Exclude parameters with significant technical issues or high variation from MA QC implementation to maintain accuracy. (Evidence: Expert opinion) 1
  • Optimize laboratory information system (LIS) settings and settings for MA QC parameters based on bias detection curves for effective implementation. (Evidence: Expert opinion) 1
  • References

    1 van Andel E, Henricks LM, Giliams APM, Noordervliet RM, Mensink WJ, Filippo D et al.. Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementation. Clinical chemistry and laboratory medicine 2022. link

    Original source

    1. [1]
      Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementation.van Andel E, Henricks LM, Giliams APM, Noordervliet RM, Mensink WJ, Filippo D et al. Clinical chemistry and laboratory medicine (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG